Clinical Decision-Making: Over the years, the patient had adequate VP device life with the 22.5Fr Provox Vega. TE voice was considered "good" with adequate tonicity, volume, fluency and intelligibility. Over the past year, she began requiring more frequent VP replacements (less than two months) with early central leakage due to biofilm formation and increased back pressure. Frequent and multiple VP replacements due to early central leakage was negatively impacting her quality of life, especially in the face of metastatic disease and ongoing oncologic treatment. The patient also had the burden of a 1.5-hour drive to the facility for TE management. The clinician considered available VP troubleshooting options that would provide this patient with a longer device life. The clinician decided to place Provox ActiValve — which is designed for patients who experience early leakage through the prosthesis. The blue fluoroplastic material of the valve flap and ring appears insusceptible to destruction by Candida.⁴  Two magnets prevent the valve flap from opening inadvertently when the user breathes or swallows.

How to Use the Provox Plug